Board Committee Change

GlaxoSmithKline PLC
07 December 2007

Issued - Friday 7th December 2007


                                   GLAXOSMITHKLINE PLC
                         ANNOUNCES CHANGE TO BOARD COMMITTEE
    
The Board has appointed Dr Stephanie Burns a member of the Corporate
Responsibility Committee with immediate effect.

A table showing the membership of the Board and its committees is attached.

S M Bicknell
Company Secretary
7th December 2007


                            ________________________

                         BOARD AND COMMITTEE MEMBERSHIP
                               WITH EFFECT FROM
                              7TH DECEMBER 2007*


Sir Christopher Gent              Chairman
Sir Ian Prosser                   Senior Independent Non-Executive Director

Dr J-P Garnier*                   Chief Executive Officer
Mr Julian S Heslop                Chief Financial Officer
Dr Moncef Slaoui                  Executive Director, Chairman, Research & 
                                  Development

Professor Sir Roy Anderson        Independent Non-Executive Director
Dr Stephanie Burns                Independent Non-Executive Director
Mr H Lawrence Culp                Independent Non-Executive Director
Sir Crispin Davis                 Independent Non-Executive Director
Sir Deryck Maughan                Independent Non-Executive Director
Dr Dan Podolsky                   Independent Non-Executive Director
Dr Ronaldo Schmitz                Independent Non-Executive Director
Mr Tom De Swaan                   Independent Non Executive Director
Sir Robert Wilson                 Independent Non-Executive Director


Board Committee              Committee Chairman          Members

Audit                        Mr Tom De Swaan              Sir Deryck Maughan
                                                          Dr Dan Podolsky
                                                          Sir Ian Prosser
                                                          Dr Ronaldo Schmitz
                                                          Sir Robert Wilson

Remuneration                 Sir Robert Wilson            Mr H Lawrence Culp
                                                          Sir Crispin Davis
                                                          Sir Christopher Gent
                                                          Dr Ronaldo Schmitz

Nominations                  Sir Christopher Gent         Sir Ian Prosser
                                                          Dr Ronaldo Schmitz

Corporate Responsibility     Sir Christopher Gent         Dr Stephanie Burns
                                                          Sir Ian Prosser
                                                          Dr Dan Podolsky
                                                          Mr Tom de Swaan


* Mr Andrew Witty, CEO Designate and Mr Chris Viehbacher, President, US
Pharmaceuticals will join the Board as Executive Directors on 31st January 2008


                      This information is provided by RNS
            The company news service from the London Stock Exchange